Analyst Insights

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends



VC Funding for AI in Drug Development & Clinical Trials Hits $5.2B

18th December 2019 – The market for AI in drug development and clinical trials is maturing and entering a new phase; total funding in the industry has reached $5.2B. Signify Research has analysed the investment landscape and categorised the industry into Information Synthesis, Drug Design and Clinical Trials.

Dedalus to Acquire Agfa’s HCIS Business: The Signify View

3rd December 2019 – Yesterday Agfa announced it had entered exclusive negotiations with Dedalus to sell part of its Healthcare IT business, here’s our take on the deal.

Trade Wars & Peace? The Radiography Market’s Reaction to Chinese-US Tariffs

21st November 2019 – The US-China trade war has been making headlines around the world since 2018 – but what effect have these tariffs had on the radiography market and how have vendors responded?

Integrated Care at Allscripts’ and InterSystems’ UK Summits

21st November 2019 – Allscripts and InterSytems recently held their UK analyst/customer events. For both integrated care in the UK was a key theme. Here’s our take on the key messages from both.

Ten factors radiologists should consider when selecting AI vendors

21st November 2019 – With over 150 independent software vendors developing machine learning solutions for medical imaging, sorting through the plethora of options to select vendors is a challenge. Here are 10 factors radiologists should consider.